wedelolactone and Sarcoma

wedelolactone has been researched along with Sarcoma* in 1 studies

Other Studies

1 other study(ies) available for wedelolactone and Sarcoma

ArticleYear
A chemo-photothermal synergetic antitumor drug delivery system: Gold nanoshell coated wedelolactone liposome.
    Materials science & engineering. C, Materials for biological applications, 2019, Volume: 101

    In this study, an antitumor drug delivery system, gold nanoshell coated wedelolactone liposomes (AuNS-Wed-Lip), were designed and synthesized. In the drug delivery system, wedelolactone liposome and gold-nanoshell were linked by l-cysteine, which had been shown an effective nanocarrier for antitumor drug delivery, on-demand drug release, and phototherapy under near-infrared (NIR) light irradiation. It was capable of absorbing 780-850 nm NIR light and converting light energy to heat rapidly. The hyperthermia promoted wedelolactone release rapidly from the systems. The release amount of AuNS-Wed-Lip under NIR irradiation reached up to 97.34% over 8 h, achieving the on-demand drug release. Moreover, a high inhibition rate up to 95.73% for 143B tumor cells by AuNS-Wed-Lip upon laser irradiation at 808 nm was observed. The excellent inhibition efficacy was also displayed in vivo antitumor study with S180 tumor-bearing mice. The results demonstrated that AuNS-Wed-Lip, as an antitumor drug delivery system, achieved chemo-photothermal synergetic effect, which has great potential in cancer therapy.

    Topics: Animals; Antineoplastic Agents; Coumarins; Drug Delivery Systems; Gold; Liposomes; Mice; Nanoshells; Phototherapy; Sarcoma

2019